JCARH125, Anti-BCMA CAR T-cell Therapy for Relapsed/Refractory Multiple Myeloma: Initial Proof of Concept Results from a Phase 1/2 Multicenter Study (EVOLVE)Sham Mailankody, Andrzej Jakubowiak, Myo Htut et al.|Blood|2018Cited by 124